Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT

Pediatr Radiol. 2013 Jan;43(1):86-92. doi: 10.1007/s00247-012-2517-9. Epub 2012 Nov 14.

Abstract

Background: Interim 18F-FDG PET helps predict outcome and tailor treatment in adults with Hodgkin disease (HD).

Objective: The purpose of this study was to assess predictive values of interim 18F-FDG PET/CT in children with HD and to define the potential added value to interim PET of low-dose CT.

Materials and methods: Children were prospectively enrolled August 2002-April 2007. PET/low-dose CT was performed at staging, after 2 cycles, at the end of treatment and during follow-up (mean 45 months). Treatment was unchanged regardless of interim results. PET and low-dose CT were read independently.

Results: Of 34 enrolled children (ages 3-17 years), 27 achieved complete response, 4 had progressive disease and 3 had relapse. Interim PET alone had positive and negative predictive values of 67% and 89%, respectively. Interim low-dose CT alone had positive and negative predictive values of 35% and 100%, respectively. Interim PET/CT had positive and negative predictive values of 75% and 96%, respectively.

Conclusions: Early interim PET/CT was a good predictor of outcome. Integrated PET and low-dose CT improved the predictive value in children with HD.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Disease Progression
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Fluorodeoxyglucose F18*
  • Follow-Up Studies
  • Hodgkin Disease / pathology*
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Multimodal Imaging*
  • Neoplasm Recurrence, Local
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Radiation Dosage
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18